Walleye Capital’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.11M Buy
+3,000
New +$1.06M ﹤0.01% 3365
2025
Q3
– Sell
-3,600
Closed -$788K – 5220
2025
Q2
$788K Buy
3,600
+2,900
+414% +$620K ﹤0.01% 2244
2025
Q1
$157K Sell
700
-700
-50% -$193K ﹤0.01% 3417
2024
Q4
$459K Buy
1,400
+400
+40% +$126K ﹤0.01% 3060
2024
Q3
$300K Sell
1,000
-2,200
-69% -$674K ﹤0.01% 3723
2024
Q2
$1.05M Buy
3,200
+2,000
+167% +$707K ﹤0.01% 2796
2024
Q1
$475K Sell
1,200
-800
-40% -$296K ﹤0.01% 3244
2023
Q4
$704K Sell
2,000
-2,100
-51% -$743K ﹤0.01% 2665
2023
Q3
$1.54M Buy
+4,100
New +$1.59M ﹤0.01% 1927

Other funds holding WST

Walleye Capital's WST Position: Q3 2026 in Review

Walleye Capital opened a new position in West Pharmaceutical (WST) in Q3 2026: 8,521 shares worth $3.16M. The stake represents ﹤0.01% of the portfolio and ranks #2368 among its holdings. This is a return to the name: Walleye Capital previously reported a position in WST as recently as Q4 2025.

Walleye Capital first reported a position in WST in Q2 2022 and has held it in 13 quarters since. The position peaked at $37M in Q4 2025. 873 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Walleye Capital held 8,521 shares of West Pharmaceutical worth $3.16M as of Q3 2026.
  • West Pharmaceutical was a new Walleye Capital position in Q3 2026.
  • West Pharmaceutical made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #2368 holding.
  • Walleye Capital first reported a position in West Pharmaceutical in Q2 2022 and has held it in 13 quarters since.
  • Walleye Capital's West Pharmaceutical position peaked at $37M in Q4 2025.
  • 873 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.